fluorescein-5-isothiocyanate has been researched along with thromboxane a2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hidaka, T; Ishizuka, T; Kawaguchi, Y; Kawakami, M; Matsuki, Y; Nakamura, H; Suzuki, K | 1 |
| Chung, KH; Hwang, KA; Kim, TJ; Lee, YH; Ryu, CK; Song, YS; Yun, YP; Zhang, YH | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and thromboxane a2
| Article | Year |
|---|---|
DP-1904, a specific inhibitor of thromboxane A2 synthesizing enzyme, suppresses ICAM-1 expression by stimulated vascular endothelial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Cell Division; Cells, Cultured; Cycloheximide; Endothelium, Vascular; Epoprostenol; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Humans; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Recombinant Proteins; Tetrahydronaphthalenes; Thrombin; Thromboxane A2; Thromboxane-A Synthase; Tumor Necrosis Factor-alpha; Umbilical Veins | 1994 |
Antiplatelet mechanism of 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304), an antithrombotic agent.
Topics: Adenosine Triphosphate; Arachidonic Acid; Calcium; Dose-Response Relationship, Drug; Fibrinogen; Fluorescein-5-isothiocyanate; Humans; Naphthoquinones; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Signal Transduction; Thapsigargin; Thrombin; Thromboxane A2 | 2001 |